Is there a link between bacteriuria and a reversible encephalopathy in dogs and cats? by Crawford, A
VIEWPOINT PIECES
Journal of Small Animal Practice  •  © 2020 The Authors. Journal of Small Animal Practice published by John Wiley & Sons Ltd on behalf of 1 
British Small Animal Veterinary Association  
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,  
provided the original work is properly cited.
Journal of Small Animal Practice (2020), 1–8
DOI: 10.1111/jsap.13178
Accepted: 21 April 2020
 
Is there a link between bacteriuria  
and a reversible encephalopathy in dogs 
and cats?
A. H. C!"#$%!&1, T. J. A. C"!&'
Clinical Science and Services, Royal Veterinary College, University of London, Hawkshead Lane, North Mymms, Hatfield,  
Herts, AL9 7TA, UK
1Corresponding author email: ahcrawford@rvc.ac.uk
Bacteriuria has been associated with abnormal neurological status in humans, especially geriatric 
patients. In this report, we review 11 cases (seven dogs and four cats) that support an association 
between bacteriuria and abnormal neurological status in veterinary medicine. These cases showed 
diffuse forebrain signs with or without brainstem signs, but primary brain disease was excluded by MRI 
and cerebrospinal fluid analysis. Bacteriological culture of urine was positive in each animal and 
neurological deficits improved or resolved with initiation of antibiosis!±!fluid therapy and leveti-
racetam. While further studies are needed to definitively confirm or refute the link between bacteriuria 
and a reversible encephalopathy, urine bacteriological culture should be considered in veterinary 
patients presented with acute onset forebrain neuro-anatomical localisation, even in the absence of 
clinical signs of lower urinary tract inflammation.
INTRODUCTION
In human medicine, bacteriuria has been associated with a range 
of neurological deficits, including confusion, delirium, drowsi-
ness, gait disturbances and worsening of pre-existing neurologi-
cal disorders such as Parkinson’s disease and stroke (Manepalli 
et al.!1990, Hufschmidt et al.!2010, Eriksson et al.!2011). Most 
commonly affecting the geriatric population, neurological def-
icits can be severe, with reports of patients presenting stupor-
ous or comatose (de Jonghe et al.!2002, Gabra et al.!2003, Sato 
et al.!2008). Neurological deficits typically improve on initiation 
of appropriate antibiotics alongside symptomatic treatment, sug-
gesting a causative link. Despite the growing body of clinical data 
supporting an association between bacteriuria and neurological 
dysfunction, definitive evidence of causation remains lacking and 
the topic continues to be a focus of clinical research and debate 
(Balogun & Philbrick!2014, Mayne et al.!2019).
Delirium has been defined as an acute onset, transient syndrome 
characterised by global impairment of cognitive function, reduced 
level of consciousness and altered psychomotor activity (Lipow-
ski!1990). Acute onset or worsening delirium has been associated 
with bacteriuria in elderly human patients (Levkoff et! al.! 1988, 
Mccue! 1993, Juthani-Mehta et al.! 2008, Eriksson et! al.! 2010, 
Mayne et al.!2019). A recent systematic review reported that clini-
cal bacteriuria was found in 26–32% of patients with delirium, 
compared to 13% without delirium. In patients with clinical 
bacteriuria, 30–35% were found to show signs consistent with 
delirium, compared to 8% without clinical bacteriuria (Balogun 
& Philbrick! 2014). However, as both delirium and bacteriuria 
are prevalent in elderly hospitalised patients (Nicolle & Long-
Term-Care-Committee!2001, Gau et al.!2009, Balogun & Phil-
brick!2014), it remains possible that the two are unrelated.
Subclinical bacteriuria is defined as bacteria in the urine with-
out associated clinical signs, while in clinical bacteriuria (i.e. 
urinary tract infection) bacteria in the lower urinary tract result 
in clinical signs such as pollakiuria, dysuria and/or haematuria 
(Weese et al.!2019). The mechanisms by which bacteriuria (clini-
cal or subclinical) cause neurological deficits are poorly under-
stood, but are suspected to be multifactorial, and may include 
hyperammonaemia, urine retention and systemic inflammation 
(Gabra et al.!2003, Albersen et al.!2007, Sato et al.!2008, Cor-
dano et al.!2014, Kenzaka et al.!2015). Neurological signs associ-
ated with bacteriuria are predominantly consistent with forebrain 
dysfunction, although in more severe cases presenting with stu-
por, coma or cranial nerve deficits, brainstem involvement is also 
thought to occur (Kalvas & Monroe!2019).
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To our knowledge, there are no veterinary reports documenting 
an association between bacteriuria and abnormal neurological status 
in dogs or cats. However, anecdotally, we suspect that this is a clini-
cal scenario encountered in veterinary medicine. In this report, we 
will review 11 cases (seven dogs and four cats) that suggest a potential 
association between bacteriuria and abnormal neurological status. 
The included cases presented with neurological deficits consistent 
with diffuse forebrain, or forebrain and brainstem, localisation, in 
which extracranial causes and structural (including inflammatory) 
brain disease were excluded, but in which urine bacteriological cul-
ture was positive, and neurological deficits promptly improved or 
resolved with initiation of antibiosis and supportive care.
MATERIALS AND METHODS
Digital medical records from January 1, 2000 to March 30, 2017 
from the Royal Veterinary College were searched for the follow-
ing terms: “urinary tract infection,” “UTI,”, “bacteriuria” and 
“encephalopathy,” “ataxia,” “obtundation,” “seizure” or “forebrain 
localisation.” Twenty-seven dogs and 11 cats with complete medi-
cal records, a history of seizures and/or neurological deficits consis-
tent with a forebrain, or forebrain and brainstem, neuroanatomical 
localisation, a positive urine bacteriological culture (48 hour aerobic 
and anaerobic culture of a urine sample collected by cystocentesis) 
and that had undergone MRI of the brain, as well as cerebrospinal 
fluid (CSF) analysis, were reviewed. Cases were excluded if clini-
cal records were incomplete or unavailable for review, or if there 
was evidence of intracranial or concurrent systemic disease, such 
as hepatic dysfunction or a portosystemic shunt, that could cause 
or contribute to the presenting neurological signs. The study was 
approved by the Institute’s Ethics and Welfare Committee.
Information retrieved from the medical records included sig-
nalment, duration and type of clinical signs, general physical 
and neurological examination findings, diagnostic test results 
[including haematology, biochemistry, plasma glucose concen-
tration, plasma ammonia concentration, urinalysis, abdominal 
ultrasound, CSF analysis (including total nucleated cell count, 
cytology and total protein concentration) and MRI], treatments 
administered, duration of hospitalisation and response to treat-
ment. Follow-up information was obtained from daily neurologi-
cal examinations while hospitalised, neurological status at hospital 
discharge, re-examination appointments at the referral hospital, 
as well as from referring veterinary surgeons’ clinical records.
CLINICAL CASES: DOGS
Seven dogs (Table!1) with a median age of 10.8 years (range 4.5–
15.25 years) presented to the neurology (n!=!6) or internal medicine 
(n!=!1) service with a history of acute onset seizures (generalised in 
two, focal in two, both generalised and focal in one), mentation 
changes (n!=!2), generalised proprioceptive ataxia (n!=!1) and abnor-
mal tremor episodes (n!=!1). The median duration of presenting 
signs was 5 days (range 2–14 days). One dog (Case 7) received diaz-
epam and phenobarbital intravenously immediately before referral, 
and one dog (Case 1) was receiving oral clonazepam. On presenta-
tion, neurological examination findings were consistent with diffuse 
forebrain dysfunction. One dog (Case 6) had clinical signs consis-
tent with urinary tract infection (pollakiuria and dysuria) and two 
dogs (Case 1, 7) had polyuria, one of which was also polydipsic with 
urinary incontinence.
The results of the diagnostic investigations are shown in 
Table!1. All dogs underwent MRI of the head, which was normal 
in five and showed Chiari-like malformation in one case, and 
T1-weighted hyperintensity of the lentiform nuclei in one case. 
This latter dog had a normal bile acid stimulation test result and 
normal findings on abdominal CT. Cerebellomedullary cistern 
CSF analysis was normal in all dogs. No dog had plasma ammo-
nia concentrations assessed. Urine sediment examination was 
performed in five dogs and revealed abundant bacteria (n!=!4) 
and white blood cells (n!=!5). Bacteriological culture of a urine 
sample collected by cystocentesis was positive in all dogs: Esch-
erichia coli (n!=!3), Enterococcus faecalis and E. coli (n!=!1), Staphy-
lococcus pseudointermedius (n!=!2) and Klebsiella spp. (n!=!1).
Pending bacteriological culture results, empirical antibiotic 
treatment was initiated in five dogs with amoxicillin clavulanate 
(n!=!4) (Clavaseptin, Vetoquinol) or cephalexin (Rilexine, Virbac) 
(n!=!1). Final antibiotic choice was based on the results of culture 
and sensitivity testing; six dogs received amoxicillin clavulanate 
and one received trimethoprim-sulfonamide (Tribrissen, Jurox). 
Six dogs additionally received intravenous fluid therapy (IVFT) 
from the first day of hospitalisation. One dog (Case 6) was receiv-
ing anticonvulsant medication (phenobarbital and potassium 
bromide) for previously diagnosed idiopathic epilepsy; serum con-
centrations were found to be within the therapeutic ranges and no 
alterations were made to the anticonvulsant treatment protocol. 
Of the four dogs that presented with acute onset seizure activity, 
and no prior history of seizures, three received levetiracetam from 
the day of hospital admission, which was continued for a median 
of 14 days (range 3–14). All cases showed a prompt and sustained 
improvement of neurological deficits and seizures within 1–3 days 
of initiating treatment. Antibiotic treatment duration was recorded 
in six dogs, with a median of 14 days (range 14–28). The median 
duration of hospitalisation was 2 days (range 1–3 days).
Follow-up information was available for six dogs (median 
follow-up time of 4.5!months, range 3–8). The dog with pre-
viously-diagnosed idiopathic epilepsy showed resolution of the 
presenting obtundation and focal seizures with antibiosis and 
IVFT. Of the remaining five dogs, four showed a resolution of 
neurological deficits, and one showed a marked improvement. 
No further seizures were observed in the four dogs presenting 
with new and acute onset seizure activity.
CLINICAL CASES: CATS
Four female neutered cats (median age of 5.5 years (range 2.5–9) 
presented to the neurology service with an acute onset of men-
tation changes (n!=!3), seizures (n!=!3; generalised in two cats 
and focal in one), inappetance (n!=!2) and proprioceptive ataxia 
affecting all limbs (n! =! 2) (Table! 2). The median duration of 
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clinical signs before presentation was 2 days (range 2–14). Two 
cats (Cases 8 and 11) received IVFT before referral, and one cat 
(Case 11) received intravenous diazepam following a seizure. 
Neurological deficits detected on presentation were consistent 
with diffuse forebrain dysfunction in two cats and forebrain and 
brainstem (reduced vestibulo-ocular reflex) neuroanatomical 
localisation in two cats. One cat (Case 11) was observed to dem-
onstrate pollakiuria and dysuria during hospitalisation.
MRI of the head and analysis of a cerebellomedullary cis-
tern CSF sample were normal in all cats. Three cats had plasma 
ammonia concentrations measured and values were elevated 
in two (Cases 9, 11). Bacteriological culture of a urine sample 
collected by cystocentesis was positive in all cats, with E. coli 
cultured in three, and E. faecalis and E. coli cultured in the 
fourth.
Empirical antibiosis with amoxicillin clavulanate was com-
menced in two cats pending the results of urine culture and sen-
sitivity. In the remaining two cats, antibiosis was commenced 
[amoxicillin clavulanate (n!=!1) and cephalexin (n!=!1)] following 
bacteriological culture and sensitivity results. All cats additionally 
received IVFT that was initiated on the day of hospital admis-
sion. Antibiosis was continued for a median of 12 days (range 
10–14). The three cats presenting with seizure activity were addi-
tionally treated with levetiracetam (for 7, 14 or 450 days), and no 
further seizures were documented. All cats showed an improve-
ment of neurological deficits and seizures within 1–2 days of ini-
tiation of treatment. The median duration of hospitalisation was 
3 days (range 1–6).
Follow-up information was available for three cats (at 5, 18 
and 19 months). Of two cats presented with generalised seizures, 
one (Case 8) made a full recovery and oral levetiracetam was dis-
continued after 15 months of seizure freedom, no further seizures 
were reported. The second cat (Case 10) received levetiracetam 
for 14 days and had no further seizures for 18 months, at which 
time seizure activity was noted and oral phenobarbital treatment 
was commenced. The remaining cat for which follow-up was 
available (Case 11) presented with lethargy and focal seizures, 
showed a resolution of clinical signs for 5!months, before acute 
development of weight loss and vomiting, at which time the 
owners elected for euthanasia without further investigations.
DISCUSSION
Case studies in humans have documented acute onset neuro-
logical deficits in patients with subclinical or clinical bacteriuria 
(Samtoy & Debeukelaer!1980, Manepalli et al.!1990, Albersen 
et!al.!2007, Hufschmidt et al.!2010, Eriksson et al.!2011,  Balogun 
& Philbrick!2014, Kenzaka et al.!2015). Prompt treatment with 
appropriate antibiotics and supportive care has been associ-
ated with rapid improvements in neuro logical status (de Jonghe 
et!al.!2002, Sato et al.!2008, Cordano et al.!2014). To the best of 
our knowledge, the potential association between bacteriuria and 
abnormal neurological status has not been investigated in vet-
erinary medicine. In this report, we review 11 clinical cases with 
acute onset neurological!deficits!that!im proved!promptly!on!ini-
tiation of treatment with antibiosis in combination with IVFT 
and/or an anticonvulsant (levetiracetam). These cases provide 
preliminary support for an association between bacteriuria and 
abnormal neurological status in cats and dogs.
Hyperammonaemia is implicated in the pathogenesis of neu-
rological deficits in patients with bacteriuria. Urease production 
by bacteria such as Proteus spp., Nocardia spp. and Staphylococcus 
aureus in the urinary tract results in the hydrolysis of urea to 
ammonia, which is subsequently absorbed into the systemic cir-
culation (Arai et al.!1989, Albersen et al.!2007). In states of hyper-
ammonaemia, glutamine release from astrocytes is impaired. The 
osmotic effect of accumulated glutamine results in cytotoxic 
oedema (Albrecht & Norenberg!2006, Salgado & Cortes!2013). 
Additional pathological consequences of hyperammonaemia 
include reduced cerebral blood flow (Rao & Norenberg!2001, 
Jalan et al.!2003, Weissenborn et al.!2004) and hyperexcitabil-
ity of neuronal cell membranes (Basile & Jones!1997, Salgado 
& Cortes!2013). Plasma ammonia levels were assessed in only 
three cases (all cats) in this series, with elevated concentrations 
detected in two (Cases 9, 11). Given this small number of cases, 
it is not possible to deduce the role of hyperammonaemia in the 
development of neurological signs in the current population. 
However, it is of note that only one animal (Case 2) in this study 
had a urease-positive pathogen (Klebsiella spp.) cultured. Human 
cases are reported with normal plasma ammonia concentrations 
and/or with infections with non-urease producing bacteria. 
Thus, other factors are likely to play a role in the development 
of neurological signs and an area of current research is the role of 
infection, sepsis and systemic inflammation (Soeno et al.!2013, 
Cordano et al.!2014, Kenzaka et al.!2015). Cytokine-mediated 
changes in blood–brain barrier permeability, impaired glutamate 
uptake by astrocytes and altered expression of "-aminobutyric 
acid (GABA) receptors may all contribute to an abnormal neuro-
logical status (Shawcross et al.!2010, Salgado & Cortes!2013). In 
the current case series, pyrexia was not documented on presenta-
tion, and mild neutrophilia was detected in only three animals, 
suggesting that systemic inflammation is unlikely to be a major 
factor in this cohort. This is in agreement with a recent study in 
which elevated rectal temperature was detected in only two of 33 
paraplegic dogs with positive urine culture (Rafatpanah Baigi et 
al.!2017). However, further studies to assess markers of inflam-
mation in blood, CSF and urine would be required to investigate 
the role of systemic inflammation in the development of neuro-
logical deficits.
Clinical bacteriuria affects approximately 14% of dogs during 
their lifetime (Ling!1984). However, a concurrent and associated 
abnormal neurological status is likely to be much less common, 
suggesting that patients presenting with neurological deficits may 
have underlying predisposing or contributing factors. In humans, 
geriatric patients are over-represented, with associated risk fac-
tors including oestrogen deficiency, urinary retention and uri-
nary incontinence (Mccue!1993, Harrington & Hooton!2000, 
Molander et al.!2000, Foxman!2002, Eriksson et al.!2010). The 
veterinary cases reported here showed a wide age range (4.5–
15.25 years in dogs; 2.5–9 years in cats) with no clear predilection 
for geriatric animals, and only one dog (Case 7) demonstrated 
Bacteriuria and abnormal neurological status
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urinary incontinence. Further investigation of predisposing fac-
tors is warranted.
A history of pollakiuria and dysuria were documented in only 
one dog (Case 6) and one cat (Case 11). The remaining cases 
in the current study were considered to have subclinical bacteri-
uria. Therefore, an absence of clinical signs of lower urinary tract 
infection should not exclude bacteriuria as a differential diagnosis 
for dogs and cats presenting with consistent neurological deficits. 
Recent guidelines from the International Society for Companion 
Animal Infectious Diseases advise that there are few indications 
for culture of urine from animals without lower urinary tract 
signs (Weese et al.!2019). We suggest that one possible indication 
may be cases with abnormal neurological status in the absence of 
other structural or functional causes.
Appropriate antibiosis and IVFT is the cornerstone of treat-
ment in human patients and is associated with a rapid improve-
ment of abnormal mental status, typically within 1–3 days (de 
Jonghe et al.!2002, Sato et al.!2008, Cordano et al.!2014, Kenzaka 
et al.!2015). An equivalent time frame for treatment response was 
found in the dogs and cats reviewed here. The majority (10 of 
11) of cases received IVFT during hospitalisation, which is likely 
to have contributed to their clinical improvement. Correction of 
pre-existing dehydration may have improved mental status, and 
the resultant diuresis would be expected to enhance renal excre-
tion of ammonia/urea and other mediators that may contribute 
to neurological deficits.
In humans, seizure activity is infrequently reported in associa-
tion with bacteriuria, with cases largely limited to children pre-
senting with febrile seizures (Mahyar et al.!2018). In contrast, the 
majority of veterinary cases reviewed in this report (four of seven 
dogs, and three of four cats) presented with a recent onset of sei-
zure activity, with three dogs and three cats receiving levetirace-
tam. Effective seizure control and resolution of postictal deficits 
is likely to have contributed to their clinical improvement. Given 
the limitations of our retrospective data set, we cannot make 
definitive conclusions that bacteriuria caused seizure activity, but 
it is interesting to note that all cases in the current report dem-
onstrated a resolution of seizure activity, as well as other concur-
rent neurological deficits, despite the short-term antibiosis and 
anticonvulsant medication courses.
The cases presented in this report were collated retrospectively 
and hence are inevitably limited by their clinical record avail-
ability, variation in diagnostic investigations and individual case 
management decisions. Plasma ammonia was measured in only 
three of the 11 cases, and future studies are needed to evaluate 
the role of hyperammonaemia in bacteriuria. While diagnostic 
investigations in each case excluded major concurrent systemic 
disease, liver function assays and organic acid assessment for urea 
cycle disorders were not performed. However, the positive, sus-
tained response to short-term treatment seen in all cases suggests 
that bacteriuria may play a role in the pathogenesis of the acute 
onset neurological deficits.
In conclusion, while direct evidence of causation remains lack-
ing, the growing body of clinical data in humans would suggest 
that bacteriuria (clinical or subclinical) should be considered as 
a potential cause of acute onset abnormal neurological status. 
This report describes seven dogs and four cats in which treat-
ment of bacteriuria resulted in sustained resolution of abnormal 
neurological status. Urinalysis, including bacteriological culture 
and sensitivity, should be performed in patients presenting with 
an acute onset of neurological deficits (particularly deficits con-
sistent with a diffuse forebrain localisation), even in the absence 
of clinical signs of lower urinary tract inflammation. Large-scale, 
prospective studies with standardised diagnostic investigations 
are needed to further evaluate the suspected link between bacte-
riuria and a reversible encephalopathy.
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